BNP Paribas Financial Markets’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158 | Hold |
134
| – | – | ﹤0.01% | 4484 |
|
|
2025
Q1 | $289 | Hold |
134
| – | – | ﹤0.01% | 4349 |
|
|
2024
Q4 | $379 | Buy |
+134
| New | +$379 | ﹤0.01% | 4344 |
|
|
2022
Q4 | – | Sell |
-134
| Closed | -$348 | – | 3459 |
|
|
2022
Q3 | $348 | Buy |
+134
| New | +$348 | ﹤0.01% | 3841 |
|
|
2022
Q2 | – | Sell |
-135
| Closed | -$1.09K | – | 3455 |
|
|
2022
Q1 | $1.09K | Hold |
135
| – | – | ﹤0.01% | 3377 |
|
|
2021
Q4 | $1.08K | Sell |
135
-51
| -27% | -$406 | ﹤0.01% | 3398 |
|
|
2021
Q3 | $2.21K | Hold |
186
| – | – | ﹤0.01% | 3183 |
|
|
2021
Q2 | $2.88K | Sell |
186
-642
| -78% | -$9.93K | ﹤0.01% | 3242 |
|
|
2021
Q1 | $19.9K | Sell |
828
-281
| -25% | -$6.74K | ﹤0.01% | 3193 |
|
|
2020
Q4 | $32.7K | Sell |
1,109
-385
| -26% | -$11.4K | ﹤0.01% | 3070 |
|
|
2020
Q3 | $22.9K | Buy |
1,494
+1,069
| +252% | +$16.4K | ﹤0.01% | 3160 |
|
|
2020
Q2 | $10.6K | Sell |
425
-1,122
| -73% | -$28K | ﹤0.01% | 3054 |
|
|
2020
Q1 | $31.6K | Buy |
1,547
+814
| +111% | +$16.6K | ﹤0.01% | 3146 |
|
|
2019
Q4 | $22.7K | Sell |
733
-67
| -8% | -$2.07K | ﹤0.01% | 3292 |
|
|
2019
Q3 | $26.7K | Buy |
800
+215
| +37% | +$7.18K | ﹤0.01% | 3180 |
|
|
2019
Q2 | $18.7K | Sell |
585
-452
| -44% | -$14.5K | ﹤0.01% | 3292 |
|
|
2019
Q1 | $29.8K | Buy |
+1,037
| New | +$29.8K | ﹤0.01% | 3185 |
|
|
2018
Q4 | – | Sell |
-163
| Closed | -$7.62K | – | 3655 |
|
|
2018
Q3 | $7.62K | Hold |
163
| – | – | ﹤0.01% | 3206 |
|
|
2018
Q2 | $13.4K | Buy |
+163
| New | +$13.4K | ﹤0.01% | 3012 |
|
|
2014
Q2 | – | Sell |
-11
| Closed | -$194 | – | 3350 |
|
|
2014
Q1 | $194 | Hold |
11
| – | – | ﹤0.01% | 2773 |
|
|
2013
Q4 | $185 | Buy |
+11
| New | +$185 | ﹤0.01% | 3470 |
|